J WOCN ■ July/August 2013 contact dermatitis, maceration, medical adhesive, medical adhesive tape, medical bandage, skin abrasion, skin injury, tape blister, and tape burn. As many of these key terms are broad, search limiters such as adhesive(s), adverse effects, skin injury, skin protection, and/or trauma were incorporated using the Boolean function "AND." After initial review of records, results were limited to articles published in English since 1990. An additional review was completed for studies investigating medical adhesive stripping published in English since 1990. This review included the following fi ve electronic databases: MEDLINE, EMBASE, BIOSIS Previews, CHEMICAL ABSTRACTS, and EMcare. Search terms included keywords for bandage or dressing or tape combined with key words for skin stripping. A separate search was conducted for relevant practice guidelines or procedures. Textbooks were not included in these searches.
In addition to randomized clinical trials and comparison cohort studies, individual case studies, multiple cases series, clinical practice guidelines, consensus documents, practice surveys, laboratory studies, preclinical research studies, technical articles, letters to the editor, and productrelated articles were retrieved. Publications outside the scope of the topic were excluded and all remaining articles (n = 167) were reviewed on a case-by-case basis by the Task Force; of these, 88 (52.6%) were considered relevant. In order to obtain a manageable cross section of key publications for consensus statement development and background information for invited panel members, each relevant article was categorized according to medical specialty and practice setting. Task Force members then ranked each article on a scale of 1 to 3 (where 1 defi ned the lowest level of information and 3 the highest), while also including as many representative specialties/practice settings as feasible. The 31 top-scoring articles (articles totaling 10 points or more) were identifi ed as key publications.
The 2-day Summit began with a presentation summarizing pre-Summit activities and state of the science, which was followed by a review of draft consensus statements. An interactive PowerPoint software program and wireless response system pads (IML ViewPoint Express and IML Click, IML, Minneapolis, Minnesota) were used to allow anonymous interactive voting by the panel members and Task Force and to capture responses. Consensus on each statement was obtained based on general principles outlined in Murphy and colleagues, 9 using 80% agreement as the criterion for consensus. If consensus was not achieved on the fi rst vote, the statement was edited based on participant input and a second, and sometimes third, vote was taken. In cases where consensus could not be reached, or if a statement was considered not relevant, consensus regarding deletion of the statement was obtained. Additional background on the establishment of the Medical Adhesives and Patient Safety Consensus Summit and its methodology can be found in Supplemental Digital Content 1, http://links.lww.com/JWOCN/A18 . convalescent center was recently reported to be $21.96 per patient per incident. 3 Healthcare providers play an important role in medical adhesive safety, but literature review reveals little guidance regarding appropriate selection and proper use of adhesive products in order to minimize MARSI. In addition, outside of clinical textbooks on wound and ostomy care, 4 -6 there is a paucity of information regarding best practices for skin care preventive strategies and application and removal techniques, as well as assessment and treatment of MARSI. For example, only 2 relevant guidelines were identifi ed in the literature: the Association of Women's Health, Obstetric and Neonatal Nurses Neonatal Skin Care Guideline 7 and evidence-based recommendations/national guidelines in Portuguese resulting from the 1st InterPele: Symposium on Skin Integrity Prevention Strategies, held in Angra dos Reis, Brazil, in March 2011. 8 In an effort to increase awareness of MARSI and defi ne best practices for its prevention, a consensus panel of 23 key opinion leaders convened to establish consensus statements on the assessment, prevention, and treatment of MARSI. Additional goals included defi ning knowledge gaps regarding medical adhesives and skin safety, documenting the spectrum of care settings and medical applications where MARSI occurs, and identifying research priorities for development of new adhesive technologies and protocols for skin protection. The interdisciplinary Medical Adhesives & Patient Safety Consensus Summit was held December 10 to 11, 2012, in St. Paul, Minnesota. An industry partner, 3M provided an unrestricted grant for the consensus summit, and a third party (Magellan Medical Technology Consultants) was contracted to manage the project.
■ Methods
Three standing members of the 3M Skin Integrity Advisory Board were invited and agreed to serve an advisory role (Task Force). Medical specialties and/or practice settings where medical adhesives are used were identifi ed and used as a guide to extend invitations to potential panel members. Specialty practice areas represented by the panel members were critical care; dermatology; electrophysiology; geriatrics; infection prevention; infusion therapy; neonatology; oncology; orthopedics; pediatrics; perioperative; physical therapy; plastic surgery; and wound, ostomy and continence. Researchers in the area of skin and wound care, including pressure ulcers, were also among the invited participants.
Literature reviews were conducted during September and October 2012. An initial search was conducted in the Scopus database using terms identifi ed by the Task Force, which included adhesive(s), adhesive surgical tape, allergic contact dermatitis, bandages, barrier fi lm, dressing, epidermal injury, epidermal stripping, fragile skin, irritant ■ Background
Medical Adhesives and Medical Adhesive Products
Literature review identifi ed several defi nitions for medical adhesives and medical adhesive tapes/bandages (Supplemental digital content 2, http://links.lww.com/ JWOCN/A20). A medical adhesive can be defi ned as a product used to affi x an external component (ie, tape, dressing, catheter, electrode, ostomy pouch, or patch) to the skin. However, selected tapes, dressings, and devices can also function as medical adhesives. According to Widman and colleagues, 10 medical adhesive tape can be simply defi ned as a pressure-sensitive adhesive and a backing that acts as a carrier for the adhesive. The US Food and Drug Administration more specifi cally defi nes a medical adhesive tape or adhesive bandage as "a device intended for medical purposes that consists of a strip of fabric material or plastic, coated on one side with an adhesive, and may include a pad of surgical dressing without a disinfectant. The device is used to cover and protect wounds, to hold together the skin edges of a wound, to support an injured part of the body, or to secure objects to the skin." 11 Medical adhesive tapes/dressings/devices are composed of several layers ( Figure 1 ). The type of backing and adhesive incorporated into the design determines the properties and performance of the adhesive product. For example, tape backings may consist of paper or a paper blend, plastic, silk (woven polyester), soft (nonwoven) cloth, traditional cloth, or foam and/or elastic. Examples of types of adhesives used in tapes and dressings include acrylates, silicones, hydrogels, hydrocolloids, and polyurethanes, as well as those that are natural-rubber latex based or contain zinc oxide. 1 ,12 Technical considerations demand that some adhesives are only paired with certain backings. Examples of adhesive dressings and dressingadhesive combinations include hydrocolloids, hydrogel sheets, foams (silicone, acrylate, polyurethane, or hydrocolloid), semipermeable transparent fi lms (silicone or acrylate), and hydrofi ber dressings ( Table 1 ) .
Medical adhesives are pressure sensitive; fi rm pressure applied to the surface of the medical tape/dressing/device will activate the adhesive by increasing the surface area contact. 12 Over time, the adhesive will warm and fl ow to fi ll in gaps between the adhesive and the irregularities in the skin surface, increasing the strength of the bond. The length of time for this process differs among the various types of adhesive products. Some softer adhesives, such as silicone, have a lower surface tension and fi ll in these gaps quickly and maintain the same level of adherence over time. Others adhesives, such as the acrylates, act more slowly, and adherence increases over time.
Medical Adhesive-Related Skin Injury
The pathophysiology of MARSI is only partially understood. Skin injury results when the skin to adhesive attachment is stronger than skin cell to skin cell attachment. Cohesive failure occurs when adhesive strength exceeds the strength of skin cell to skin cell interactions. As a result, the epidermal layers separate or the epidermis separates completely from the dermis. Even when there is no visible trauma, adhesive removal commonly results in detachment of varying amounts of superfi cial epidermal cell layers; repeated application and removal result in compromised skin barrier function and initiate infl ammation and the wound healing response. The association of a specifi c product with skin stripping or J WOCN ■ July/August 2013 larly in premature infants, resulting in increased transepidermal water loss, evaporative heat loss, and permeability. 24 Removal of any layers of the neonatal stratum corneum during the process of adhesive removal can further reduce the skin's barrier function, which signifi cantly compromises fl uid balance and homeostasis and increases skin permeability; this leads to potential toxicity and irritation from topically applied substances, as well as an increased risk of infection. In addition, the cohesion between the dermis and epidermis is lower in neonatal skin than in adult skin, increasing the risk for select skin injuries. 12 A number of skin changes inherent to the aging process increase the risk of skin injury in older adults. These include loss of dermal matrix and subcutaneous tissue; epidermal thinning; reduced cohesion between the dermal and epidermal layers; reduced vascularity, elasticity, tensile strength; and loss of moisture. 1 ,23,24 injury arises from a combination of factors, including energy required to remove the adhesive (often measured in Newtons), the rheology of the adhesive, its occlusiveness, and the rigidity of the material used as tape backing. 13 For example, rigid tape backing can lead to injury if there is skin movement due to edema or joint movement. 14 , 15 Trapping of moisture beneath an occlusive tape may result in maceration and irritation, which renders the skin more vulnerable to mechanical trauma. Types of MARSI are described in Figure 2 .
Various intrinsic and extrinsic factors also infl uence the risk of skin injury ( Table 2 ). For example, age-related physiologic factors exert a major impact on a patient's susceptibility to MARSI. 1 , 12 , 23 Neonatal skin is 40% to 60% thinner than adult skin, largely due to the presence of fewer epidermal cell layers in the stratum corneum. 12 This underdeveloped stratum corneum provides a less-effi cient barrier, particu- J WOCN ■ July/August 2013 at the extremes of life (in the elderly and neonates). 1 , 16 ,29, 30 In a 1-day prevalence audit, 8% of hospitalized infants and children were found to have tape-related skin stripping. 29 In the 2003 National Pediatric Pressure Ulcer and Skin Breakdown Prevalence Survey, the prevalence of skin stripping related to adhesive tape was reported as 17%. 30 One clinical setting where the incidence of MARSI has been fairly well documented is orthopedic surgery. Tension injuries or blisters are more prominent in this setting as a result of multiple factors, including the use of large amounts of tape to hold large compression bandages securely. In this setting, the risk of tape damage is compounded by joint movement, skin friction, and the presence of tissue edema, which creates a strapping effect. The incidence of tension blisters has been reported to be in the range of 6% to 41% following knee or hip surgery 18 , 19 ,31-33 and 0% to 6% following knee arthroscopy. 34 Medical adhesives are a common contributor to skin tears 20 , 35 and are a critical concern in caring for the elderly and for patients with compromised skin. In the International 2010 Skin Tear survey, dressing removal was cited as one of the top causes of skin tears. 20 During a 12-month period, the Pennsylvania Patient Safety Authority reported tape as the third most common cited cause of skin tears, following hospital beds and patient Emerging evidence suggests that differences in skin structure and function among various ethnic groups may affect their risk of skin injury. These include racial differences in percutaneous absorption rates of various substances as well as stratum corneum lipid (ceramide) content, which is highest in African Americans. 25 More recently, ethnic differences in tensile mechanical properties of the dermis have been demonstrated, suggesting that African American skin is more rigid than nonHispanic white skin, which may affect risk of injury. 26 Additional intrinsic factors that can increase the risk of MARSI include a number of dermatologic and underlying medical conditions, malnutrition, and dehydration; extrinsic factors such as drying of the skin, prolonged exposure to moisture, certain medications, radiation therapy, photodamage, and previous use of adhesive products also play an important role in enhanced susceptibility to skin injury ( Table 3 ) 21, 22 .
Epidemiology
The prevalence of skin injury due to adhesives is largely unknown. In one prospective cohort study of older individuals admitted to a long-term care facility, the cumulative incidence of skin injury caused by adhesive tape was reported to be 15.5% (incident density 38 per 1000 persondays). 27 Clinical manifestations of MARSI observed in this study included contact dermatitis (71%), trauma (21%), and infection (9%). The use of adhesives was also identifi ed as the primary cause of skin breakdown among neonatal intensive care unit patients in a nursing research utilization project involving 2820 newborns. 28 Tape-related skin (epidermal) stripping can occur at any age and in any clinical setting, but it is especially prevalent Removal at a high angle Insuffi cient support of the skin at the peel line when removing the adhesive product
Repeated taping or dressing changes
Accurate description of the skin and any lesions can help distinguish adhesive-related skin damage from other nontraumatic dermatologic disorders or conditions and may help identify an infectious process if present. In patients with deeply pigmented skin, mild erythema may not be apparent and lesion color may vary from that seen in persons with lighter skin tones.
2. For all medical adhesive-related skin injuries, a comprehensive assessment should be performed to determine severity and guide management.
If an MARSI is noted during a skin assessment or device change, the injury should be assessed and the severity determined in order to guide management. As a whole, mechanical injuries (skin stripping, tension injuries, and skin tears) may be assessed as general wounds and classifi ed according to depth (ie, superfi cial, partial thickness, or full thickness). 41 The Neonatal Skin Condition Scale, 42 a validated assessment tool that incorporates evaluation of dryness, erythema, and skin breakdown, provides an objective measurement of skin condition and may be used in clinical practice to assess MARSI in this patient population. Existing skin tear assessment and classifi cation systems, such as the PayneMartin or Skin Tear Audit Research instruments, are not widely accepted, 20 and there currently are no such systems for other adhesive-related injuries in clinical practice. Although it may be diffi cult to clinically distinguish between irritant and allergic dermatitis, a thorough assessment may identify distinguishing features and enable determination of severity, thus guiding appropriate management. 43 Identifi cation of allergic dermatitis is important, since the patient should be advised regarding future avoidance of the same or similar materials (see the following section). Assessment for evidence of infection should be performed in all cases of MARSI.
Assessment-Allergy/Sensitivity
3. Obtain a history of patients' known or suspected allergies and sensitivities to minimize the risk of medical adhesive-related skin injury.
Medical adhesive products are a common cause of nonallergic irritant contact dermatitis, 10 , 27 ,44 and such reactions are more likely to occur with extended exposure. 10 Allergic contact dermatitis related to adhesive products occurs much less frequently than irritant contact dermatitis, although numerous case reports of allergic reactions to components of adhesive products can be found in the literature. 10 , 44 Because avoidance of the causative substance is key to the prevention and management of dermatitis, 43 it is prudent to obtain a history of a patient's known or suspected allergies, as well as any previous episodes of irritant contact dermatitis, before using an adhesive product.
transfers. 35 The units where skin injury occurred most often included medical/surgical, intermediate care, rehabilitation, and specialty units.
■ Consensus Defi nitions

Medical Adhesive
Panel members established the following defi nition for a medical adhesive:
A medical adhesive is a product used to approximate wound edges or to affi x an external device (ie, tape, dressing, catheter, electrode, pouch, or patch) to the skin.
Medical Adhesive-Related Skin Injury
Konya and associates defi ne skin injury due to adhesive tape as "a condition in which persistent erythema or other skin injury is evident even 60 minutes after removal of the tape." 27(p1237) Building upon this terminology, and based on the use of a 30-minute timeframe to defi ne erythema persistence in the defi nition of stage 1 pressure ulcers in guidelines developed by the Wound, Ostomy and Continence Nurses Society in 1988 36 and in measurement of alterations in skin barrier function following adhesive removal in some research trials (eg, Lund and colleagues 37 
■ Consensus Statements
Assessment-General 1. During use of adhesive-containing products, the skin should be assessed for evidence of damage on a daily basis or with adhesive device changes; this is especially important for those patients deemed to be at high risk for adhesive-related injury.
It is a widely accepted standard of care that skin be assessed on all patients on admission to a healthcare facility and then at regular intervals, with more frequent assessment of patients at higher risk for skin breakdown or damage. 7 , 38 , 39 Assessment of the skin is particularly important during the use of adhesive-containing products, particularly in patients at high risk for adhesive-related injury. Skin inspection requires thorough observation and data collection, followed by interpretation. 40 Good lighting is essential for this process. The skin should be assessed for color, texture, uniformity of appearance, and integrity. Any lesions should be described accurately with regard to type, color, arrangement, size, and distribution.
J WOCN ■ July/August 2013 6. Care of the skin, including prevention of adhesive-related injury, should be a standard of care for all healthcare providers.
Skin care is an important aspect of patient care. Because medical adhesives play such an integral part of healthcare delivery and affect nearly every patient, prevention of MARSI is paramount to good patient care. A number of preventable causes of MARSI were found in the literature or identifi ed by the consensus panel members ( Table 4 ) . By addressing these issues, the risk of skin injury can be reduced.
Prevention of medical adhesive-related skin injuries is facilitated by good nutrition and hydration.
Proper nutrition and hydration are important aspects of good skin care and overall patient health. Overall nutrition should include adequate calories, amino acids, carbohydrates, and fats, as well as trace minerals and vitamins that are essential components for maintaining intact and healthy skin.
Prevention-Selection, Application, and Removal
Selection 8. Select the most appropriate adhesive product based on its intended purpose, the anatomic location, the adhesive will be applied to, and the ambient conditions present at the application site.
9. Appropriate product selection entails consideration of properties of adhesive-containing products such as adhesive gentleness, breathability, stretch, conformability, and fl exibility.
When selecting an adhesive product, one must consider both patient-and product-related factors. Perhaps 4. The incidence of true allergic contact dermatitis related to adhesives is not known; suspected allergic contact dermatitis should prompt consideration for referral and/or appropriate investigation (such as patch or scratch tests).
If there is a high suspicion of allergic contact dermatitis and/or irritant contact dermatitis cannot be ruled out, one should consider referring the patient for further evaluation. If avoidance and empiric treatment do not resolve a suspected case of allergic contact dermatitis, patch testing may be indicated. 43 The clinician can contact the manufacturer of the adhesive product in question for further assistance in identifying potential allergens. However, while the components of the adhesive may contribute in some way to the adverse reaction, it is neither logical nor possible in many cases to separate out these components for testing; it is the fi nal combination that is the product, not necessarily its constituent parts.
Prevention-General
5.
Identifi cation of patients at high risk for medical adhesive-related skin injury is a key component of prevention.
As noted previously, a number of physiologic and pathologic conditions and extrinsic factors have an adverse effect on skin structure and function and thus can increase the risk of skin injury (refer to Table 2 ). Therefore, identification of patients who may be at increased risk for MARSI is a key component of prevention, as extra precautions can often be taken to help protect the skin from injury. These include the use of gentler adhesives, barrier products, and medical adhesive removers. 
Recommended Procedures for Applying and Removing Adhesive-Containing Products 4,5,45,58
Application Removal
Ensure that the area is clean and dry. Clip hair if necessary. Apply an alcohol-free skin barrier fi lm to protect at-risk skin. Allow all preps to dry thoroughly before applying the adhesive product. Apply the adhesive product without tension, pulling, or stretching. If desired, an edge could be folded over to form a tab to facilitate removal. Smooth the adhesive product into place with fi rm gentle pressure, avoiding gaps and wrinkles. Use gentle, stretchable adhesive products if edema/ movement is anticipated, considering the direction of the stretch when securing the product. If compression is needed, stretch the adhesive over the dressing only and press remaining tape onto skin without tension.
Loosen the edges of the adhesive product. If there is no folded edge/tab already in place, a small piece of tape may be affi xed to an edge of the product to form a tab to facilitate removal. With the fi ngers of the opposite hand, push the skin down and away from the adhesive. Remove the adhesive product low and slow back over itself in the direction of hair growth, keeping it horizontal and close to the skin surface. As the product is removed, continue moving fi ngers of the opposite hand as necessary to support newly exposed skin. Nonbordered transparent fi lm dressings may also be removed by loosening a corner of the dressing and stretching it horizontally in the opposite direction of the wound (stretch and relax technique). Walk fi ngers under dressing to continue stretching it. One hand continuously supports the skin adhered to the fi lm dressing. The process can be repeated around the dressing. Tape strips may be removed by slowly removing each side toward the wound. When both sides are completely loosened, lift the strip up from the center of the wound. Use medical adhesive remover if needed to loosen the adhesive bond. Consider using lotion, petrolatum, or mineral oil if not reapplying an adhesive product to the same area.
tube has moved out of position. 50 As such, the more critical the device, the greater the need for use of a higheradhesion product and/or a stronger backing. Higheradhesion products and/or stronger backings are usually necessary for securing items such as heavy tubing and immobilization splinting.
11. Exercise caution when using silicone adhesives to secure some devices as this may result in suboptimal adherence or adhesion failure.
Silicone adhesives adhere poorly to other silicone products, and research into medical silicone technology has not produced a silicone adhesive formulation that adheres well to plastics. 51 While silicone adhesives are commonly used for wound dressings and in securement of lightweight tubes and devices, products such as silicone adhesive tapes have not been evaluated for use as primary securement of critical tubing. For this reason, caution should be exercised when using silicone adhesives to secure critical tubes and devices and frequent monitoring is essential to ensure that proper securement is maintained.
Selection and Application
Anticipate changes in skin and/or joint movement following injury and operative or other procedures when selecting and applying medical adhesive products.
Tension injuries or blisters represent a separation of the epidermis from the dermis, which is more likely to occur when the skin is stretched underneath an unyielding tape or when a joint or other area of movement is covered with an unyielding tape. 31 As noted earlier, the incidence of tension injuries in the orthopedic surgery setting can be high. For example, in the case of hip surgery, tension forces can develop beneath the posterior dressing when the skin moves as a result of fl exion of the hip. 33 However, skin movement can normally be expected in any area of the body affected by joint articulation or tissue expansion or movement. In addition, skin movement may occur in other areas of the body due to edema resulting from infl ammation, injury, or operative and other procedures. To minimize the risk of tension injuries in these situations, an adhesive product that stretches should be applied so that the direction of stretch corresponds with the direction of movement.
Anticipate skin movement with edema when selecting and applying medical adhesive products.
Potential skin movement should also be considered in cases of edema that occur unrelated to infl ammation, injury, or operative and other procedures. Edema can occur in a wide the foremost patient consideration is the intended use or purpose of the product (ie, securement of a critical device, noncritical device, or dressing; wound closure; etc). The intended use of the product, in turn, infl uences anticipated wear time. The clinician should then consider anatomic location and skin thickness, as well as the ambient conditions present at the site. Key considerations include whether the area is smooth or contoured, subject to movement or friction, or exposed to moisture, perspiration, humidity, irritants, exudate, and/or body fl uids.
The intrinsic characteristics of all components of an adhesive product must then be taken into account to address these patient factors. Properties of the adhesive to be considered include cohesiveness over time and gentleness; properties of the tape/backing/dressing to be considered include breathability, stretch, conformability, fl exibility, and strength. The goal is to select a product that will fulfi ll the intended purpose for the anticipated wear time, at the specifi c anatomic location, and under the conditions present. The clinician must remember that it is the combination of the adhesive and the backing that give the adhesive product its overall characteristics.
Silicone adhesives represent a newer type of medical adhesive, and limited evidence suggests that these products are gentler than other types of adhesives and associated with lower risk of skin injury due to their physical properties. 1 , 15 ,46,47,49 Silicone adhesives have lower surface tension than traditional adhesives, which allows them to conform to the skin's natural contours and to rapidly create a secure bond. 48 In contrast to conventional adhesives, which gradually increase contact with the skin surface and therefore increase adhesion over time, silicone adhesives contact the entire skin surface quickly and the adhesion then remains constant over time. These properties result in less peel force (defi ned as the average amount of force required to remove an adhesive product from the skin), less propensity for epidermal cell stripping, and less discomfort upon removal. In addition, some silicone adhesive products can be repositioned if needed.
10.
Consider the potential adverse consequences of insuffi cient adhesion and/or adhesive failure, when selecting medical adhesive products for use in securing a critical device.
Critical devices include those for which there is a risk of signifi cant clinical impact to a patient if the device is dislodged or does not perform as expected. Examples include vascular access devices, endotracheal tubes, nasogastric feeding tubes, and indwelling urinary catheters. Proper securement of critical devices is paramount to patient safety. For example, inadequately secured vascular access devices increase the risk of phlebitis, infection, and catheter migration or displacement. 49 Displacement of a small-bore nasogastric feeding tube can have dire consequences; for example, aspiration of a substance because a However, current neonatal skin care guidelines recommend avoidance of alcohol because of its drying effects. 7 , 12 Due to the neonate's high body surface-toweight ratio, defi cient stratum corneum, and certain skin immaturity factors, the guidelines also recommend avoidance of solvents containing hydrocarbon derivatives or petroleum distillates due to risk of toxicity. These guidelines also recommend that barrier products be limited to use of pectin or hydrocolloid barriers, or barrier fi lms, such as an alcohol-free skin protectant, which is recommended for use in infants over 30 days of age. In clinical practice, pectin and hydrocolloid barriers are used more often in neonates as a platform for adhesives because they allow better molding and attachment. However, limited evidence suggests that skin injury can occur with the use of these products. 37 As a result, siliconebased skin barrier fi lms are often used off label in neonates regardless of age. Use of these barrier fi lms has been described in neonates 54 and premature infants, 57 but further research is needed.
Limit or avoid substances, such as compound tincture of benzoin, which increase the stickiness of adhesives.
Substances that increase the stickiness of adhesives, sometimes referred to as tackifi ers or bonding agents, may be used to increase the cohesive strength of an adhesive, particularly when it is subject to stress. They increase the fl ow and spread of an adhesive on the surface of the skin, thus increasing immediate adhesion. Such agents are usually low-molecular-weight materials that are derived from natural products, such as rosin (eg, tincture of benzoin) or citrus peels, or from petroleum-based compounds. However, the enhanced adherence provided by such substances may lead to skin injury with adhesive removal and should be avoided, particularly in neonates. 7, 12 Panel members concurred that the use of these agents should be limited to selected adult patients when enhanced adhesive adherence is needed.
Application and Removal
Use proper application and removal techniques for adhesive-containing products.
Proper application and removal of adhesive-containing products are critical to minimizing skin damage. Recommended procedures for applying and removing adhesive-containing products are summarized in Table 3 . It is important that adhesive-containing products not be applied under tension (strapping), as this can lead to tension injuries. 45 , 58 In addition, rapid, vertical pulling has been shown to generate a higher peel force than slow removal while keeping the adhesive product horizontal and folded onto itself. 59 range of medical conditions, including allergic reactions, cirrhosis, congestive heart failure, deep vein thrombosis, hypoalbuminemia, chronic kidney disease, burns, sepsis, and fl uid overload, such as might be seen in critical care settings. 's lines) and the effects of medical adhesive products when applied with the lines or against/across these lines.
Application
Consider the role of skin tension (Langer
Langer's lines, also known as tension or cleavage lines, correspond to the alignment of collagen fi bers within the dermis and the direction in which the skin is under the highest tension and has the least extensibility. 52 Surgical incisions, and especially cosmetic procedures, are made parallel to the direction of Langer's lines because this approach is associated with better healing and less scarring. Skin movement is more likely across Langer's lines, where the skin tension is lower; if it is necessary to apply adhesive products across these lines, it would be benefi cial to use products that stretch. In contrast, reduced skin movement and potentially fewer tension injuries are anticipated if a rigid adhesive product is applied parallel to Langer's lines. Nevertheless, evidence supporting clinical applications of these principles is lacking and additional research is needed to more clearly defi ne application of adhesive devices along or in parallel to the direction of Langer's lines.
Consider application of a skin barrier prior to applying an adhesive product.
Skin barrier products provide a protective interface between the skin and adhesives and are recommended to reduce the risk of MARSI and to protect the skin from body fl uids, exudates, urine, and stool. 4 , 5 Most commonly available as liquid barrier fi lms (foams, wipes, or sprays), they may be composed of silicones, acrylates, organic polymers, or inorganic compounds dispersed in a solvent. Following application of a liquid barrier fi lm, the solvent evaporates, forming a transparent, breathable, protective coating. Some barrier fi lms also include an added component (plasticizer) that allows fl exibility in the applied product. Pectin-based products are also available.
Clinical studies have demonstrated the ability of barrier fi lms to reduce erythema and skin stripping following medical adhesive removal in various patient populations, including neonates, 53, 54 , 55 as well as their ability to protect periwound skin. 56 For these reasons, the use of barrier products prior to adhesive product application should be considered, particularly in patients at high risk for skin injury. Use of barrier products in neonates and in the periwound and ostomy setting is particularly important, given the propensity for compromised skin integrity.
Infection Prevention
Adhesives may promote overgrowth of microorganisms. Monitor sites exposed to adhesive materials for manifestations of infection.
Several researchers have documented increased bacterial growth beneath occlusive tapes. 62 , 63 Adhesives may also promote overgrowth of yeasts and saprophytic fungi. 64 , 65 Therefore, any site exposed to adhesive materials should be monitored for evidence of localized or systemic infection. Signs and symptoms of localized bacterial infection include increased pain, edema, erythema, warmth, or suppuration (eg, presence of pustules, folliculitis, or furunculosis). Signs and symptoms of localized fungal infection include, but are not limited to, an erythematous maculopapular rash with satellite papular or pustular lesions.
As with any skin injury, those that result from the use of adhesive-containing products may lead to localized or systemic infections, particularly in vulnerable populations. 1, 12, 18 These include patients with factors or comorbid conditions that compromise immune function, such as diabetes, renal failure, malignancy, solid organ transplantation, or a history of or current use of immunosuppressive drugs; surgical patients; as well as the elderly, neonates, and premature infants.
Store and use adhesive-containing products in a manner that prevents contamination.
Medical adhesive products have been documented in the literature as potential reservoirs of pathogenic microorganisms as early as 1974. 66 -70 For example, one study demonstrated that 59 of 80 tape specimens (74%) collected at various clinical areas in one hospital were found to be colonized by pathogenic bacteria. 65 More recently, Harris and colleagues 70 documented that 11 of 21 samples (52%) of partially used surgical adhesive tapes collected from several clinical areas of three hospitals in Australia were contaminated with multiresistant organisms (methicillin-resistant Staphylococcus aureus and/or vancomycin-resistant enterococci). 70 These reports represent case studies or investigations with small sample sizes where only rates of colonization were determined. However, as medical adhesive products are used to affi x items that come into contact with blood, normally sterile tissue, or mucous membranes, there is the potential for infection with use of products that are not packaged as single use, particularly many tape products, as well as certain barrier products, ostomy supplies, and other medical adhesive devices. For example, pectin-based adhesive skin barrier sheets were implicated in a 5-year outbreak of S aureus in a neonatal unit in the United Kingdom. 71 In addition, outbreaks of cutaneous Rhizopus infection have been reported with the use of adhesive products such as polyethylene tape, 72 ostomy pouches, 73 and elasticized adhesive dressings used over surgical wounds. 67, 68 Cases of cutaneous mucormycosis associated 18. Consider use of medical adhesive removers to minimize discomfort and skin damage associated with removal of adhesive products.
Removing medical adhesive products can strip layers of the stratum corneum, causing skin injury and pain to the patient. Medical adhesive removers are used in clinical practice to aid in removal of adhesive products and to remove adhesive and barrier fi lm residues. The 3 main types of medical adhesive removers are alcohol or organic solvent-based, oil-based, or silicone-based. They may be formulated as wipes, pads, or sprays. Of these, the silicone-based removers are the newest, often being promoted as being "no-sting" because they do not contain alcohol.
Medical adhesive removers have not been studied in neonates. Current neonatal skin care guidelines recommend avoidance of alcohol and organic solvent-based medical adhesive removers and recommend slow and careful removal using water-soaked cotton balls to continuously wet the adhesive-skin interface. 7 Alternatively, mineral oil or petrolatum can be used to loosen tape in cases where retaping is not necessary.
Prevention--Electrodes
To prevent electrochemical burns under adhesive electrodes, powered (battery and line voltage) equipment should be maintained and monitored for dangerous leakage currents.
Electrical components and devices are encased in nonconducting insulation to ensure that the electric current is contained within the unit and follows the intended pathway through the device's electrical circuit. If this insulation deteriorates or is damaged, current will leak through the insulation and fl ow to the ground. These leakage currents can cause electrochemical burns under adhesive electrodes, as the electrode connection and/or the adhesive itself are electrically conductive. Direct current leakage currents, such as from batteries, are particularly dangerous.
Normally, leakage currents are felt by the patient as a shocking or tingling sensation near an applied electrode. However, electrochemical injuries have been reported in anesthetized patients connected to battery-operated medical devices as a result of leakage currents. 60 Typically, these injuries can be differentiated from other electrical injuries such as burns due to allergic or chemical reactions or thermal burns, due to the fact that they appear different on the anode, where the reaction is acidic versus the cathode, where the reaction is alkaline. 60 , 61 All types of powered equipment should be properly maintained and monitored to measure leakage currents to verify that they are electrically safe. 61 Each piece of equipment should be examined prior to use to ensure that it has been recently inspected and tested, that insulation and connectors are clean and intact, and if battery operated, that any batteries are secure and covered.
J WOCN ■ July/August 2013 this form of dermatitis, there is some evidence that they may compromise barrier function and some recommend steroids be avoided. 43 Cool compresses and low-to mid-potency topical steroids (eg, hydrocortisone butyrate, desonide, or triamcinolone) can be used to reduce the infl ammation seen with allergic contact dermatitis. Folliculitis should be treated with proper skin hygiene and topical and/or oral antibiotics as needed. If an MARSI does not respond to conservative management within 7 days or if the wound deteriorates despite conservative care, an appropriate skin or wound care specialist should be consulted.
Future Research
25.
Further research is needed to expand the scientifi c knowledge of adhesive performance and use, including mechanisms of medical adhesive-related skin injury, prediction, prevention, assessment and documentation, and treatment.
Consensus panel members identifi ed a number of areas where further research is needed to expand the scientifi c knowledge of adhesive performance and use ( Table 5 ) .
with the use of temperature probes and monitoring electrodes in neonates have also been reported. 74, 75 As such, any medical adhesive product that is not packaged as single use should be stored and used in a manner that prevents contamination. Boxes containing multiple items should remain closed and ideally, individual items brought to the patient's bedside as needed. Clean items should be separated from those that are frequently touched and/or have already been used (eg, adhesive tape rolls). Items such as adhesive tape rolls should not be left on contaminated surfaces or carried around in pockets or on stethoscopes, and strips of tape should not be placed on bedrails, tables, or other potentially contaminated surfaces prior to application on the patient.
22
. Single-patient-use adhesive products are preferred.
Federal and Centers for Disease Control guidelines suggest that, to help prevent cross-contamination, nondisposable patient items that cannot be cleaned and disinfected between patients, such as adhesive tape, should be dedicated for use only on a single patient. 76, 77 Because adhesive tape has the potential to act as a signifi cant fomite, Harris and colleagues 70 recommend that short rolls of medical adhesive tape be supplied in sealed packets for individual patient use. Many adhesive products, such as dressings, are already packaged as single-use items and manufacturers now offer adhesive tape in single-patient-use rolls for the reasons cited previously. 78 Therefore, single-patient-use adhesive products should be used whenever possible. The same general principles used to manage other acute wounds should be employed when treating adhesiverelated skin injuries (refer to the National Guidelines Clearinghouse, http://www.guidelines.gov , for examples of wound care guidelines). Specifi c guidance regarding the management of skin tears has recently been published. 20 After an initial assessment to determine the severity of the adhesive-related injury, the wound should be cleansed with a noncytotoxic solution to remove adhesive residue, bacteria, and cellular debris. Afterward, a therapy that supports moist wound healing should be applied. Irritant contact dermatitis can be managed with use of lipid-rich moisturizers to improve the damaged skin barrier and use of cool compresses for acute infl ammation. Although topical steroids are often used initially to control infl ammation in 
Recommended Areas for Further Research
Mechanisms of MARSI
Although much physiologic data regarding wounds and wound healing exists in the literature, there is less adhesive-specifi c research in this area, particularly how the various components of adhesive products interact to cause injury, as well as specifi c adhesive measurements, such as surface energy, viscosity, and skin adherence.
Prediction
Further clarifi cation of adhesive-specifi c risk factors for skin injury is needed.
Prevention
There is a need to study potentially benefi cial products (eg, skin protectants and silicone adhesive removers) in neonates and premature infants, as there are limited data of use of these products in this patient population.
Assessment and documentation
Tools for clinical assessment and documentation of MARSI are lacking. Currently, the relative degree of MARSI can be estimated only by in vivo, side-by-side comparisons of objective and subjective measurements under identical experimental conditions. Objective measurements include TEWL, the number of cells or amount of protein removed, cutaneous confocal microscopy, and colorimetric measurement of erythema. 13 , 37 Subjective measurements, which are typically used in the clinical setting, include overall skin appearance (ie, presence of vesicles or bullae) and degree of erythema or dryness following repeated adhesive applications.
Treatment
Identifi cation of best practices to facilitate healing of MARSI is needed.
Abbreviations: MARSI, medical adhesive-related skin injury; TEWL, transepidermal water loss.
■ Conclusions and Recommendations for Practice
Panel members were in agreement that MARSI is farreaching and affects patients of all ages across all settings of care. The care of the skin, including its protection against MARSI, is a basic requirement for patient care. Healthcare providers should strive to prevent and reduce the incidence of MARSI but fi rst must be made aware of the problem and its causes. They, as well as patients and caregivers, need to be provided with the knowledge and tools necessary for preventing and managing adhesive-related injury. Best practice guidelines are needed to assist those who use medical adhesives in using them appropriately, identifying patients at risk for skin injury, and implementing prevention and management strategies. A glossary of terms used in this document can be found in Supplemental Digital Content 2, http://links.lww.com/JWOCN/A19 .
KEY POINTS
✔ Expert opinion suggests that appropriate selection of adhesive products and the use of proper application and removal techniques can help minimize MARSI.
✔ Expert opinion recommends considering the role of skin tension and anticipating skin and/or joint movement when selecting and applying medical adhesive products.
✔ Expert opinion recommends that adhesive-containing products be stored and used in a manner that prevents contamination, and that single-patient-use products be used whenever possible.
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